Overmedication has put type 2 diabetics at risk of low blood sugar

Diabetes has downstream effects on the heart, eyes, kidneys, and more

High blood sugar levels in untreated diabetes roughen artery walls, increasing plaque buildup, heart disease, and high blood pressure risk. High levels also cause acid to build up in the bloodstream, potentially making the brain swell, the lungs fill with fluid, and the heart to beat arrhythmically—all fatal complications.

Type 2 diabetes is a chronic disease that develops over time

Almost 90 to 95% of people with diabetes have Type 2 diabetes, occuring when the pancreas doesn't make enough insulin or the insulin fails to work correctly. Insulin malfunction causes the pancreas to crank out increasingly high amounts of the blood sugar-regulating hormone, leading to overwork and reductions in production.

Type 1 diabetes, affecting about 5%-10% of people with diabetes, is an autoimmune disorder inhibiting insulin production.

An overview of 200 years of diabetes treatment

Diabetes treatment became truly effective after the advent of insulin injections in the early 1900s. Diabetes is becoming increasingly common. Current trends estimate one in three Americans will have diabetes by 2050. This overview explores two centuries of diabetes treatment—starting in 1812—and outline potential challenges to treatment and prevention.

Every 3.5 minutes in the US, a limb is amputated due to diabetes.

Diabetes 101: Insulin deficiency leads to high glucose levels in the blood

Glucose, the brain's preferred energy source, enters the bloodstream when the body breaks down consumed carbohydrates. To manage this increase in readily available energy, the body releases the hormone insulin, which allows glucose to enter and fuel our cells. Without insulin, glucose remains in the blood, causing health issues.

One in 10 adults worldwide has diabetes.

Blood Pressure and Diabetes

New meta-analysis shows blood pressure reductions with ACE inhibitors and ARBs are associated with a lower diabetes risk, but other types of antihypertensive agents have the opposite effect.

The myth of sugar rushes vs. the reality of sugar crashes

It's generally accepted that sugar rushes are a myth, and that hyperactivity is a more psychological experience. However, there is real science behind the rare sugar crash that primarily impacts those with diabetes. Read this article to understand how historical and cultural factors have shaped sugar perceptions, and how low blood sugar can trigger shakiness, fatigue, weakness, and more in diabetes patients.

Diabetes is a chronic disease linked to insulin production and high blood sugar

Diabetes is a chronic, progressive disease caused by a lack of, or problems processing, the hormone insulin, leading to persistently high blood sugar. Around 90 to 95% of cases are Type 2 (chronic and caused by factors like diet and environment). The remainder are Type 1 diabetes (an autoimmune disorder).

Black patients are losing their limbs at a rate triple that of other groups due in large part to inequities in diabetes care and management.

Diabetes is a hormonal disorder that occurs when the pancreas does not produce enough of a hormone that regulates blood glucose, called insulin, or when the body cannot effectively use the insulin it produces.

Gestational diabetes occurs when the body can't produce insulin during pregnancy

Globally, pregnant people are increasingly at risk to develop gestational diabetes due to rising maternal ages and obesity rates. The condition is associated with heavier fetal weight, congenital abnormalities, and perinatal mortality, which includes stillbirths and deaths of babies younger than 7 days old.

The popularity of new weight loss drugs has led to a diabetes treatment shortage

The FDA approved Ozempic to help patients with diabetes, but the popularity of semaglutide as a weight loss drug led doctors to prescribe Ozempic to nondiabetic patients who needed to lose weight. Ozempic became so popular that manufacturers could not keep pace with demand, posing risks for Ozempic-users with diabetes.

The discovery of insulin led to a controversial Nobel Prize in 1923

For centuries, Type 1 diabetes was fatal. The 1920s "discovery" of insulin netted two of its creators—Frederick Banting and his boss, John Macleod—a Nobel prize. Separately, the German doctor Georg Zuelzer synthesized an effective version of the life-saving drug years earlier but was interrupted by World War I.

The lack of guidance on getting off GLP-1s leaves patients at risk

Dr. David Kessler, former FDA Commissioner and public health leader, explores how these drugs override the brain’s reward-driven eating habits but have notable side effects. These include developing eating disorders, muscle loss, and intestinal obstruction.

This Texas city is having an 'amputation crisis'

Texas has some of the highest rates of diabetes-related amputations in the country. Towering over the rest of the Longhorn state is the city of San Antonio, where men are nearly three times as likely to lose a limb to diabetes than women. This article explains how men in this majority Mexican American city are genetically and culturally at risk of Type 2 diabetes, a disease involving issues with the blood sugar-regulating hormone insulin.

Type 1.5 diabetes is typically found in adulthood

Clinically referred to as latent autoimmune diabetes in adults, or LADA, this condition is often diagnosed as Type 2 diabetes. However, it’s an autoimmune disease that eventually requires insulin, just like Type 1 diabetes. Misdiagnosis can result in uncontrolled high blood sugar and a slew of other serious health issues.

Fiji's 'quiet' diabetes crisis

Across the Pacific archipelago of Fiji, diabetes often avoids diagnosis until amputation or death is imminent. Fiji's government has said nearly 30% of its population has diabetes, and, in 2019, related amputations accounted for 40% of the country's hospital operations. This "sugar disease" may have such a stronghold on the archipelago, which has a physically active culture that prizes locally sourced foods, due to cost, with processed foods being much cheaper than alternatives.

Vitamin D supplement pills are linked to rising cases of vitamin D toxicity in the US

Vitamin D deficiency is common. But taking Vitamin D supplements in doses exceeding 4,000 IU/day (a measurement of vitamin biological activity) for prolonged periods can raise bodily concentrations of this vitamin to dangerous values. US National Poison Data indicates that the annual average of vitamin D poisonings from 2000-05 was 196, but this rose by 1,600% to 4,535 per year for the period of 2005-11.

Telehealth demand for GLP-1s is on the rise as people seek it out for myriad reasons—the proportion of non-obesity and non-diabetes-related prescriptions for the drug soared from 4.5% in 2018 to 17% in 2023.

People with schizophrenia have triple the risk of developing diabetes

It remains contentious if something inherent about the disease or antipsychotics' side effects (weight gain) are mostly to blame. Some newly diagnosed schizophrenia patients already have insulin resistance, raising questions about if patients' brains are getting enough energy from glucose, and if dietary changes—like a high-fat, low-carbohydrate, moderate-protein diet—may help alleviate symptoms.

Gummy vitamins have candy-level sugar—and that sweetness is linked to overdoses

A typical gummy vitamin contains about the same amount of sugar in a single serving as one Sour Patch candy. It's linked to the increase in pediatric overdoses for products including multivitamins and melatonin. Gummy formulations also degrade quickly, so they often include much higher levels of the product in each serving than the label advertises—boosting overdose risks due to this unchecked variability. (Some users may experience a paywall.)

Risks of GLP-1s include health side effects, counterfeit drugs, and more

This episode interviews researchers and patients who have used semaglutide to explore some of the potential risks associated with using the drug to lose weight. These include insurance challenges, health scares related to counterfeit versions of these drugs, and some users lose their ability to enjoy food.

Read the FDA's statement on concerns over compound pharmacies

GLP-1 drugs popularity for weight loss and treating diabetes, led to a significant supply shortage and the rise of compound pharmacies, which produce customized drug formulations but lack formal approval from regulators. The drugs are ostensibly the same, but manufacturing methods lead to variations in concentration, filler compounds, and more.

Is it possible to cure diabetes?

Treatments for diabetes depend on the type of condition a patient has. Gestational diabetes typically goes away after birth, and those with Type 2 diabetes may be able to reverse their condition through diet, exercise, and blood sugar management. Type 1 diabetes has no cure, but can be successfully managed.

See how much daily sugar substitute intake the FDA considers to be safe

The agency states in this PDF graphic that a person weighing about 132 pounds would have to consume roughly a couple dozen sweetener packets daily—or more—to reach unsafe levels of consumption. The accumulated consumption would be across all sources, including diet beverages, sugar-free candies, and actual packets added to coffee.

Insulin is a hormone that controls blood sugar by helping absorb it into cells

Blood sugar levels increase after a meal when the body starts turning food into usable fuel—sugars, proteins, and more—which are absorbed into the bloodstream through the intestines. Blood sugar levels rise, releasing insulin, and letting sugar in the blood be absorbed into hungry cells, thereby dropping blood sugar levels.

The dark side of modern sugar production

Humanity's ancestors evolved to wring more calories from sugary fruits by storing excess sugar as fat, an adaption that's culminated in many peoples' palettes preferring calorie-rich sweet. Now, the desire for sugar has both contributed to a widespread health crisis and been at the center of atrocities around the world.

In 2023, Americans spent more than $50B on weight loss drugs, a number expected to triple or more by the end of the decade.

Immunosuppressants enable organ transplants, but come with severe side effects

This drug cocktail helps to lower your body's natural response to attack a transplanted organ. Such medications usually need to be taken for a lifetime after receiving an organ and can come with serious side effects including high blood pressure, diabetes, increased risk of some cancers, and high cholesterol, among others.

The term 'low T' was coined in 2002, recasting testosterone therapy and elevating demand.

GLP-1s are linked to reduced worker illness and cost savings—a 2026 economic analysis finds the weight-loss drugs are tied to a 17% drop in worker sick leave days.

Addressing lifestyle factors, which influence inflammation, can cure some chronic diseases

In this video, a physician claims that he reversed a patient's Type 2 diabetes in six weeks by addressing inflammation drivers such as diet. More broadly, he argues that society needs to better consider and address numerous disease factors that are modulated by inflammation, such as stress, sleep, diet, and movement.

The American Heart Association says adults can safely drink up to five cups of coffee per day and regular consumption may improve cardiovascular health.

GLP-1 drugs, first used to manage diabetes, were derived from Gila monster saliva.

How weight loss drugs could reduce obesity costs

A detailed analysis from finance giant ING finds semaglutide and other weight loss drugs could significantly drive down global costs stemming from heart disease and other health problems associated with obesity. The benefits will vary, depending on each country’s demographics and drug and healthcare costs.

Addictive drugs can cause dopamine levels to become ten times higher than normal.

Sugar alcohols, a type of carbohydrate used as a sweetener, may elevate risk of heart attacks and strokes.

A 201-level at how GLP-1 drugs lead to appetite reduction

It's well-established that drugs which mimic the hormone GLP-1 can help people lose weight and control blood sugar levels, primarily through appetite reduction. This technical review provides an overview of how both natural and therapeutic GLP-1 interacts with the gut and brain to produce its effects.

Certain medications that affect blood flow or mood boost the risk of heatstroke

Drugs that narrow blood vessels, beta blockers that regulate blood pressure, diuretics, antidepressants, and antipsychotics can all affect the body's ability to regulate its internal body temperature, and so individuals taking these medications need to take special care in extreme heat and when exercising in hot conditions.

Fake sugars may disrupt metabolic health.

Genetic drug matching, called pharmacogenomics, can help avoid dangerous drug reactions

Certain gene variants can affect how quickly or slowly medications are broken down in the body, affecting drug effectiveness and the risk of drugs failing. Such testing is often not covered by insurance companies though research indicates if these tests were performed for more than six drugs across the US population, avoided ailments would likely climb into the hundreds of thousands. (Some users may encounter a paywall.)

How meal timing factors into health outcomes

The world is trending toward weight gain, a development that comes with a corresponding rise in risk for health conditions, including diabetes and heart disease. This article explores how meal timing has become a factor in nutrition and weight maintenance.

See which GLP-1 drugs are currently approved (along with their cost)

Around 75% of prescriptions for GLP-1 drugs are used to treat diabetes, while the remainder is used for weight loss. This overview from GoodRX includes a list and overview of currently available options along with prices for each.

Celebrities are able to promote prescription drugs on social media without any required mention of potential side effects due to a legal loophole.

Diabetes drug GLP-1 is a peptide (that's what the 'P' is for).

Saccharin was banned in Canada in the 1970s, but regulators may allow its use once again

The product, commonly known as Sweet'N Low, was banned in Canada in the late 1970s due to research indicating that the sweetener could cause cancer in lab rats. Subsequent studies have found that the rodent findings didn't hold true for humans, and so Canadian regulators state that they are considering updating their stance to allow the product to be added to certain foods (the product is currently allowed in the US).

Understanding insulin

Scientists Daniel and Kelly talk with researcher Dr. Katrine Whiteson about diabetes, the history of insulin production, and Dr. Lydia Villa-Komaroff—an essential member of the team who discovered that bacteria could be induced to produce insulin. Listen to discover interesting facts about the life-saving medicine and how it works in the human body.

Xylitol, a sugar alcohol, is sometimes added to foods at 1,000 times the level seen naturally in foods

This article covers the latest research in sugar alcohols and heart health. Some work indicates that after consuming sugar alcohols erythritol or xylitol people are at an elevated risk of developing blood clots, which can cause heart attacks and strokes. Both substances occur in low levels naturally in fruits and vegetables and are also produced by the human body, but as sweeteners in foods they are present at exponentially higher levels.